PillEye is a medical utility app for pharmacists and veterinarians that automates pill counting via camera recognition on iOS and Android.
Product velocity
Active
Daily rank 🇺🇸
#199
Medical · free
Sentiment
3.7
2k reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
Users hire PillEye to eliminate manual labor in inventory management, but the current subscription-first design forces a trade-off between professional efficiency and recurring cost.
For Pharmacists, pharmacy technicians, veterinarians, and healthcare professionals managing medication inventory.
Key features
Real-time pill counting via camera feed, supporting up to 1,000 pills simultaneously.
Static image capture to count up to 500 pills with 99.99% accuracy.
Tablet-only feature using a hardware prism attachment to monitor counting while viewing the screen.
How much does it cost?
Freemium model utilizing in-app purchases to monetize professional pharmacy workflow tools.
Velocity
Active developmentShow more...
5 versions in history. Development pace: active.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads frustrated. Users appreciate high accuracy in counting large volumes of tablets during live photo mode sessions.
How are ratings & reviews evolving?
What users say, by theme
- High accuracy in counting large volumes of tablets during live photo mode sessions
- Aggressive subscription pricing model creates significant friction for professional and casual users alike
49 of 49 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for PillEye – tablet, pill counter
How's the Medical market?
PillEye holds a #14 Grossing position in the US Medical category, but the Grossing rank lags behind the Free chart entry, signaling monetization friction relative to its discovery advantage.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for PillEye – tablet, pill counter
Where is it heading?
The pharmacy utility market is shifting toward integrated fulfillment and adherence, leaving PillEye's standalone counting tool exposed to churn. The current monetization strategy is the primary driver of negative sentiment, so the PM must pivot to a more flexible pricing model to prevent long-term user attrition.
- The transition to a subscription-first model drives high churn, which compounds the negative sentiment trend visible in recent reviews.
- Recent updates focus on tablet-specific hardware features, but fail to address the core stability and login complaints from professional users.
The SWOT
- 99.99% accuracy in object recognition
- Prism Mode creates B2B equipment moat
- Multi-user logs support audit trails
- Offline-mode for clinical environments
- B2B partnerships with pharmacy systems
- Lifetime license tiers to reduce churn
Next best moves
Ship offline-capable counting because mandatory network dependency is a top complaint → restore clinical usability
+ 1 more prioritized moveThe counter-intuitive read
The high subscription price is not just a monetization error…
Read the full takeFeature gaps
Medication adherence tracking (available in Medisafe but missing here) +1
Since the last report: The app has pivoted to a high-cost subscription model, triggering negative sentiment and churn, while simultaneously refining its feature set to focus on hardware-integrated counting.
Bottom line
PillEye provides industry-leading counting accuracy, but the aggressive subscription model and network dependency alienate professional users, so the PM must prioritize offline functionality and flexible pricing to stabilize retention.
Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated